LV12200A - Anti-diabetic agent - Google Patents

Anti-diabetic agent

Info

Publication number
LV12200A
LV12200A LV970131A LV970131A LV12200A LV 12200 A LV12200 A LV 12200A LV 970131 A LV970131 A LV 970131A LV 970131 A LV970131 A LV 970131A LV 12200 A LV12200 A LV 12200A
Authority
LV
Latvia
Prior art keywords
diabetic agent
diabetic
agent
Prior art date
Application number
LV970131A
Other languages
Latvian (lv)
Other versions
LV12200B (en
Inventor
Janina Briede
Mara Stivrina
Egils Bisenieks
Janis Uldrikis
Natalija Makarova
Janis Poikans
Gunars Duburs
Karlis Heidemanis
Original Assignee
Latvijas Organiskas Sintezes Instituts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Latvijas Organiskas Sintezes Instituts filed Critical Latvijas Organiskas Sintezes Instituts
Priority to LVP-97-131A priority Critical patent/LV12200B/en
Priority to PCT/LV1998/000005 priority patent/WO1999001432A1/en
Publication of LV12200A publication Critical patent/LV12200A/en
Publication of LV12200B publication Critical patent/LV12200B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
LVP-97-131A 1997-07-03 1997-07-03 Antidiabeic agent LV12200B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
LVP-97-131A LV12200B (en) 1997-07-03 1997-07-03 Antidiabeic agent
PCT/LV1998/000005 WO1999001432A1 (en) 1997-07-03 1998-06-30 Anti-diabetic agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LVP-97-131A LV12200B (en) 1997-07-03 1997-07-03 Antidiabeic agent

Publications (2)

Publication Number Publication Date
LV12200A true LV12200A (en) 1999-01-20
LV12200B LV12200B (en) 1999-04-20

Family

ID=19736322

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-97-131A LV12200B (en) 1997-07-03 1997-07-03 Antidiabeic agent

Country Status (2)

Country Link
LV (1) LV12200B (en)
WO (1) WO1999001432A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005020977A1 (en) 2003-08-21 2005-03-10 Wisconsin Alumni Research Foundation Alpha-ketoglutarate potentiators of insulin secretion
WO2013076516A1 (en) 2011-11-24 2013-05-30 Lipidart Kutató Fejlesztő És Tanácsadó Kft. 1,4- dihydropyridine derivatives with hsp modulating activity

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2650013C3 (en) * 1976-10-30 1981-04-02 Bayer Ag, 5090 Leverkusen 1,4-Dihydro-2,6-dimethyl-4- (3-nitrophenyl) -3,5-pyridinedicarboxylic acid isopropyl (2-propoxy-ethyl) ester, process for its preparation and medicinal products containing it
GR851819B (en) * 1984-08-17 1985-11-26 Wyeth John & Brother Ltd
US4757071A (en) * 1984-12-14 1988-07-12 Nisshin Flour Milling Co., Ltd. 1,4-dihydropyridine derivatives, and pharmaceutical compositions containing same, useful for treating cardiovascular diseases
EP0324626A1 (en) * 1988-01-13 1989-07-19 Korea Research Institute of Chemical Technology 1,4-Dihydropyridine derivatives
GB8804439D0 (en) * 1988-02-25 1988-03-23 Pfizer Ltd Dihydropyridines
GR1002248B (en) * 1988-03-08 1996-04-23 Egyt Gyogyszervegyeszeti Gyar 1,4-dihydropyridine derivatives preparation method
DE59410255D1 (en) * 1993-12-10 2003-04-17 Bayer Ag Phenyl-substituted 1,4-dihydropyridines with cerebral activity
US5405855A (en) * 1993-12-23 1995-04-11 Andrulis Pharmaceuticals Corp. Treatment of insulin resistant diabetes with thalidomine

Also Published As

Publication number Publication date
WO1999001432A1 (en) 1999-01-14
LV12200B (en) 1999-04-20

Similar Documents

Publication Publication Date Title
NO20001602L (en) Business Agent
DE69840201D1 (en) Verschleissanordnung
DE69832429D1 (en) Wobbelsignalerfassungschaltung
DE69821393D1 (en) LEITWEGLENKUNGSPROXY
DE69817568D1 (en) ELEKTROCHEMILUMINESZENZDETEKTOR
DE69819648D1 (en) Zweitorpuffer
NO20001494L (en) over Lies
NO995147D0 (en) contrast agents
DE69821038D1 (en) Aufhängungsstabilisieurung
FI972855A0 (en) Propulsionsenhet
DE69814051D1 (en) RELEASE AGENT
DE69833962D1 (en) STRAHLUNGSTERMOMETER
DE69804086D1 (en) TRANSIENTBILDSTRUKTUR
ATA111897A (en) KIMME
NO20002555L (en) Extension
LV12200A (en) Anti-diabetic agent
DE59811562D1 (en) Brieftaubenkonstatiersystem
FI970496A0 (en) Sidobegraensare
FI973848A0 (en) Baerbar faeltprocesseringsanordning
ATA145497A (en) SULFATIC-HYDRAULIC BINDING AGENT
FI971344A0 (en) En vattenavlaegsningsanordning Foer en former
SE9704714D0 (en) Bonding agent
SE9401674D0 (en) Agent
NO974138D0 (en) contrast agents
KR970021293U (en) Patent Application Form